Cargando…

Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) pandemic have spurted in three major waves in India at different times and had different levels of severity in different waves. The objective of our study was to determine the comparative mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gul, Shujat, Ali, Asifa, Sheikh, Nawaz Ahmad, Gul, Irfan, Sheikh, Tariq Sultan, Prajjwal, Priyadarshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465047/
https://www.ncbi.nlm.nih.gov/pubmed/37649761
http://dx.doi.org/10.4103/jfmpc.jfmpc_2318_22
_version_ 1785098594348433408
author Gul, Shujat
Ali, Asifa
Sheikh, Nawaz Ahmad
Gul, Irfan
Sheikh, Tariq Sultan
Prajjwal, Priyadarshi
author_facet Gul, Shujat
Ali, Asifa
Sheikh, Nawaz Ahmad
Gul, Irfan
Sheikh, Tariq Sultan
Prajjwal, Priyadarshi
author_sort Gul, Shujat
collection PubMed
description INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) pandemic have spurted in three major waves in India at different times and had different levels of severity in different waves. The objective of our study was to determine the comparative mortality rate in three COVID-19 waves and determine the factors associated with mortality. METHODS: We identified a cohort of 1,132 COVID-19 patients who were admitted between April 14, 2020 and February 08, 2022 at our center. All the admitted patients with positive COVID–polymerase chain reaction were included in the study. Sample characteristics were determined by screening age, sex, socio-economic status, occupation, symptomatology of COVID, patient status on admission, baseline investigations, comorbidities, medical history, oxygen dosage needed during admission, the span of hospital stay, diagnosis, and vitals such as blood pressure, pulse, and oxygen saturation. All the data were procured from an institutional database. RESULTS: In total, 1,132 patients included in the study, the mean age was 65.08 ± 12.29 and 56% were males. The affliction rate was 42.13% in >60 years, 29.5% in 46-60 years, 20.8% in 31-45 years, and 7.4% in 30 years’ group. In the first, second, and third waves of COVID-19, the mortality rates were 13.21%, 23.53%, and 11.39%, respectively. Among the comorbidities, mortality rates were proportionately higher in those with hypertension (6.7%), and diabetes (5.5%), than those with chronic obstructive pulmonary disease (3.3%), chronic kidney disease (CKD) (1.5%), heart disease (1.6%), and malignancy (0.2%). CONCLUSION: We identify the peaked mortalities in the second encounter which was predicted by age, comorbidities such as hypertension, and diabetes.
format Online
Article
Text
id pubmed-10465047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-104650472023-08-30 Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience Gul, Shujat Ali, Asifa Sheikh, Nawaz Ahmad Gul, Irfan Sheikh, Tariq Sultan Prajjwal, Priyadarshi J Family Med Prim Care Original Article INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) pandemic have spurted in three major waves in India at different times and had different levels of severity in different waves. The objective of our study was to determine the comparative mortality rate in three COVID-19 waves and determine the factors associated with mortality. METHODS: We identified a cohort of 1,132 COVID-19 patients who were admitted between April 14, 2020 and February 08, 2022 at our center. All the admitted patients with positive COVID–polymerase chain reaction were included in the study. Sample characteristics were determined by screening age, sex, socio-economic status, occupation, symptomatology of COVID, patient status on admission, baseline investigations, comorbidities, medical history, oxygen dosage needed during admission, the span of hospital stay, diagnosis, and vitals such as blood pressure, pulse, and oxygen saturation. All the data were procured from an institutional database. RESULTS: In total, 1,132 patients included in the study, the mean age was 65.08 ± 12.29 and 56% were males. The affliction rate was 42.13% in >60 years, 29.5% in 46-60 years, 20.8% in 31-45 years, and 7.4% in 30 years’ group. In the first, second, and third waves of COVID-19, the mortality rates were 13.21%, 23.53%, and 11.39%, respectively. Among the comorbidities, mortality rates were proportionately higher in those with hypertension (6.7%), and diabetes (5.5%), than those with chronic obstructive pulmonary disease (3.3%), chronic kidney disease (CKD) (1.5%), heart disease (1.6%), and malignancy (0.2%). CONCLUSION: We identify the peaked mortalities in the second encounter which was predicted by age, comorbidities such as hypertension, and diabetes. Wolters Kluwer - Medknow 2023-07 2023-07-14 /pmc/articles/PMC10465047/ /pubmed/37649761 http://dx.doi.org/10.4103/jfmpc.jfmpc_2318_22 Text en Copyright: © 2023 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gul, Shujat
Ali, Asifa
Sheikh, Nawaz Ahmad
Gul, Irfan
Sheikh, Tariq Sultan
Prajjwal, Priyadarshi
Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title_full Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title_fullStr Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title_full_unstemmed Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title_short Comparative assessment of SARS CoV2-associated mortalities in 3 COVID waves and related risk factors: The South Kashmir’s experience
title_sort comparative assessment of sars cov2-associated mortalities in 3 covid waves and related risk factors: the south kashmir’s experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465047/
https://www.ncbi.nlm.nih.gov/pubmed/37649761
http://dx.doi.org/10.4103/jfmpc.jfmpc_2318_22
work_keys_str_mv AT gulshujat comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience
AT aliasifa comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience
AT sheikhnawazahmad comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience
AT gulirfan comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience
AT sheikhtariqsultan comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience
AT prajjwalpriyadarshi comparativeassessmentofsarscov2associatedmortalitiesin3covidwavesandrelatedriskfactorsthesouthkashmirsexperience